Pharmacokinetic considerations in the use of anticancer drugs during pregnancy: challenges and new developments
Authors:
- David J BellDBDavid J Bell
- David J KerrDKDavid J Kerr
- 12 June 2015
- journal article
- Published by Informa Healthcare in Expert Opinion on Drug Metabolism & Toxicology
- Vol. 11 (9) , 1-4
Abstract
Cancer complicates approximately 0.1% of all pregnancies, and the incidence is expected to increase, as more women elect to defer child-bearing to a later age. For these women and the clinicians treating them, there is little rigorous evidence with which to guide their management, but thought must be given to the effects of chemotherapeutic agents on the developing fetus and the effects of physiological changes within the pregnant women. We examine the evidence available for the effects of cytotoxic chemotherapy on the development of the fetus and for the health of the child in the longer term, and the effects of transplacental transfer and physiological changes of pregnancy on the pharmacokinetics of these drugs. These factors may have significant influence on the appropriate dosing of chemotherapeutic agents in pregnant women, compared to their nonpregnant counterparts, and further research is required into the implications of these findings for the successful treatment of cancer in pregnancy.Keywords
This publication has 11 references indexed in Scilit:
- Pregnancy-associated breast cancer: optimal treatment optionsInternational Journal of Women's Health, 2014
- Prognosis of Women With Primary Breast Cancer Diagnosed During Pregnancy: Results From an International Collaborative StudyJournal of Clinical Oncology, 2013
- Transplacental transfer of anthracyclines, vinblastine, and 4-hydroxy-cyclophosphamide in a baboon modelGynecologic Oncology, 2010
- Adverse neonatal outcomes: examining the risks between preterm, late preterm, and term infantsAmerican Journal of Obstetrics and Gynecology, 2008
- Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in uteroCancer, 2006
- Long-term evaluation of cardiac function in children who received anthracyclines during pregnancyAnnals of Oncology, 2005
- Use of chemotherapy during human pregnancyThe Lancet Oncology, 2004
- Coexistence of Pregnancy and MalignancyThe Oncologist, 2002
- Hematological Malignancies and Pregnancy: A Final Report of 84 Children Who Received Chemotherapy In UteroClinical Lymphoma, 2001
- Growth and development of children of mothers treated with chemotherapy during pregnancy: Current status of 43 childrenAmerican Journal of Hematology, 1991